Addex therapeutics logo
Addex therapeutics logo

Addex therapeutics

addextherapeutics.com
addextherapeutics.com • HQ: Geneva, Switzerland • Venture - Series Unknown 2023 • 11-50 employees
HQ: Geneva, Switzerland • Venture - Series Unknown 2023 • 11-50 employees
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

About us Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

People

Robert Lutjens
Executive Officer
SEC Form D
Roger Mills
Executive Officer, Director
SEC Form D
Mikhail Kalinichev
Executive Officer
SEC Form D
Jean-Philippe Rocher
Executive Officer
SEC Form D
Timothy Dyer
Executive Officer, Director
SEC Form D
Raymond Hill
Director
SEC Form D
Jake Nunn
Director
SEC Form D
Isaac Manke
Director
SEC Form D
Vincent Lawton
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Geneva Switzerland
HQ
10-50 est. staff

Financials

Total raised
$13.9M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $3.7M Details
Venture - Series Unknown 2022 $4.2M Details
Convertible Note 2021 $5.9M Details